American International Group, Inc. Alpine Immune Sciences, Inc. Transaction History
American International Group, Inc.
- $27.6 Billion
- Q1 2024
A detailed history of American International Group, Inc. transactions in Alpine Immune Sciences, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 18,949 shares of ALPN stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,949
Previous 16,185
17.08%
Holding current value
$0
Previous $308,000
143.83%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ALPN
# of Institutions
186Shares Held
62MCall Options Held
158KPut Options Held
199K-
Decheng Capital LLC Menlo Park, CA8.32MShares$044.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.78MShares$02.76% of portfolio
-
Black Rock Inc. New York, NY3.58MShares$00.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.13MShares$06.52% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.08MShares$00.01% of portfolio
About ALPINE IMMUNE SCIENCES, INC.
- Ticker ALPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,006,700
- Description
- Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...